- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
CRO Partner and NetraMark have formed a partnership to utilize artificial intelligence for the analysis of clinical trial data.
1 report, 1 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CRO Partner and NetraMark have formed a partnership to utilize artificial intelligence for the analysis of clinical trial data.
Keep exploring
Part of
Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Also in this story
- Recursion Pharmaceuticals, Merck KGaA, and Tempus expanded collaborations to leverage multimodal datasets and launch AI models for drug discovery.
- Every Cure and Predictive Oncology Inc. formed a strategic collaboration to use AI for drug repurposing.
- Tempus AI and Northwestern Medicine partnered to enhance AI-powered clinical care and boost investor confidence.
- Viva Biotech and V-DEL are utilizing technology to support continuous drug discovery and target triage.